We are live on ! Find out more
SCL.PR.CL

STEPAN COMPANY 5 1/2% CV PFD

Delisted

SCL.PR.CL was delisted on the 31st of July, 2013.

0 hedge funds and large institutions have $0 invested in STEPAN COMPANY 5 1/2% CV PFD in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 20 (-2)

100% less capital invested

Capital invested by funds: $104K → $0 (-$104K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
Holders Change
-2
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
U
UBS
Switzerland
-$100K
2
Barclays
Barclays
United Kingdom
-$4K
Name Holding Trade Value Shares
Change
Change in
Stake
U
1
UBS
Switzerland
-$100K -790 Closed
Barclays
2
Barclays
United Kingdom
-$4K -32 Closed

SCL.PR.CL Hedge Fund Activity: Q3 2013 in Review

0 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in STEPAN COMPANY 5 1/2% CV PFD (SCL.PR.CL) for Q3 2013, worth a combined $0 — down 100% from $104K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SCL.PR.CL and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS, exiting entirely with an estimated $100K sold.

  • 0 institutional investors held STEPAN COMPANY 5 1/2% CV PFD (SCL.PR.CL) as of Q3 2013, down from 2 in Q2 2013.
  • Funds reported $0 of STEPAN COMPANY 5 1/2% CV PFD stock for Q3 2013, down 100% quarter-over-quarter.
  • 0 funds opened new STEPAN COMPANY 5 1/2% CV PFD positions in Q3 2013 and 2 closed out, a net change of -2 holders.
  • The largest STEPAN COMPANY 5 1/2% CV PFD seller in Q3 2013 was UBS, an estimated $100K sold.

Based on aggregated 13F filings for Q3 2013.